BlackRock Fund Advisors’s Argos Therapeutics, Inc. ARGS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $2.23M | Buy |
22,784
+3,015
| +15% | +$295K | ﹤0.01% | 3148 |
|
|
2016
Q3 | $1.97M | Buy |
19,769
+5,685
| +40% | +$565K | ﹤0.01% | 3163 |
|
|
2016
Q2 | $1.73M | Buy |
14,084
+12,647
| +880% | +$1.55M | ﹤0.01% | 3214 |
|
|
2016
Q1 | $184K | Sell |
1,437
-119
| -8% | -$15.2K | ﹤0.01% | 3497 |
|
|
2015
Q4 | $72K | Buy |
1,556
+892
| +134% | +$41.3K | ﹤0.01% | 3810 |
|
|
2015
Q3 | $64K | Sell |
664
-18
| -3% | -$1.74K | ﹤0.01% | 3783 |
|
|
2015
Q2 | $93K | Buy |
682
+82
| +14% | +$11.2K | ﹤0.01% | 3749 |
|
|
2015
Q1 | $107K | Buy |
600
+406
| +209% | +$72.4K | ﹤0.01% | 3611 |
|
|
2014
Q4 | $39K | Buy |
+194
| New | +$39K | ﹤0.01% | 3685 |
|
|
2014
Q2 | – | Sell |
-4,908
| Closed | -$982K | – | 3991 |
|
|
2014
Q1 | $982K | Buy |
+4,908
| New | +$982K | ﹤0.01% | 3192 |
|